Anika Therapeutics | ANIK - Deudores Comerciales

Precio De Mercado
14.99
Cambio Diario
0.49 3.38%
Mensual
4.68%
Anual
-0.40%
Q2 Expectativa
13.85




Deudores Comerciales Cambio Fecha
Abbott USD 10.4B 166M 2025-09
Agenus USD 22.44M 1.14M 2025-12
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 140.86M 75.6M 2025-12
Integra LifeSciences USD 278.85M 16.69M 2025-12
Intrexon USD 1.02M 559K 2024-06
J&J USD 17.61B 235M 2025-09
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
MacroGenics USD 13.37M 55.86M 2025-12
Merit Medical Systems USD 223.61M 7.9M 2025-12
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 397M 100M 2025-12
Smith & Nephew USD 1.48B 85M 2025-12
Stryker USD 4.04B 396M 2025-12
Surmodics USD 23.56M 288K 2025-06
Veracyte USD 44.66M 3.17M 2025-12
Xencor USD 29.3M 7.49M 2025-12
Zimmer Biomet Holdings USD 1.7B 106.1M 2025-12